A Phase III Study of DPPE Combined With Epirubicin and Cyclophosphamide vs Epirubicin and Cyclophosphamide Alone as First Line Treatment in Metastatic/Recurrent Breast Cancer
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Cyclophosphamide; Epirubicin; Tesmilifene
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors YM BioSciences
- 26 Jul 2007 The expected completion date for this trial is now 1 Jun 2006.
- 02 Feb 2007 Status changed from in progress to discontinued.
- 19 Aug 2005 New trial record.